#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antiphospholipid antibodies Autoinflammation with infantile enterocolitis Idiopathic intracranial hypertension Acute myeloid leukaemia (in remission) Granulomatosis with polyangiitis Hereditary angioedema with C1 esterase inhibitor deficiency Marginal zone lymphoma recurrent Congenital disorder of glycosylation Myocarditis Scleroderma associated digital ulcer Hormone-dependent prostate cancer Angiosarcoma Angiosarcoma non-metastatic Stevens-Johnson syndrome Ewing's sarcoma More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma Medulloblastoma recurrent – Basic Information Ornithine transcarbamoylase deficiency – Treatment Antisynthetase syndrome Leukoencephalopathy – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Von Willebrand’s disease – Life with Disease Leiomyosarcoma metastatic – Life with Disease Angelman’s syndrome – Trials in Disease Adrenocortical carcinoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [14C]ZIPALERTINIB Esomeprazole Clindamycin Phosphate Epirubicin Hydrochloride Voxelotor TIFCEMALIMAB 68Ga-Nota-Abscint-Her2 ANERATRIGINE MESILATE Lovo-B Bilastine Acetylcysteine Dobutamine Hydrochloride Specific Nucleic Acid Sna-Veru Op-1250 Sitagliptin Oxazepam Grwd5769 Solrikitug Azd3470 Amikacin More therapies…

    Learn about Your Condition

    HER2 positive gastric cancer Liver transplant Embolism Aortic stenosis Progressive supranuclear palsy Non-obstructive cardiomyopathy Body mass index increased Basal cell naevus syndrome Neck pain Hairy cell leukaemia recurrent Foetal growth restriction Fibromyalgia Tetanus Rheumatic disorder Chronic granulomatous disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitaetsklinikum Knappschaftskrankenhaus Bochum…

Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH

In Der Schornau 23-25, Langendreer, Bochum, 44892, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Austria France Germany Italy Spain

  • Study on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Blinatumomab
    • Imatinib
    • Ponatinib
    Germany

  • Study on MB-CART2019.1 for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible for High-Dose Chemotherapy and Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma recurrent
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Gemcitabine Hydrochloride
    • Oxaliplatin
    Austria Belgium Croatia Czechia Finland France +9

  • Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Austria Belgium Czechia Denmark France Germany +4

  • Study of Meclofenamate Sodium and Temozolomide for Patients with Progressive MGMT-Methylated Glioblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Meclofenamate Sodium
    • Temozolomide
    Germany

  • Study on the Effects of Immunoglobulin A, G, and M in Patients with Peritonitis and Sepsis After Infection Control

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritonitis
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Immunoglobulin A
    • Immunoglobulin G
    • Immunoglobulin M
    Austria Germany

  • Study on Early Sedation with Dexmedetomidine vs. Placebo for Older Critically Ill Patients on Ventilators

    Recruiting

    3 1 1
    Finland Germany Ireland The Netherlands Spain

  • Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin
    • Venetoclax
    Austria Belgium Estonia Finland Germany Lithuania +2

  • Study on Hilar Cholangiocarcinoma Treatment Using Porfimer Sodium and Foscan for Patients with Bile Duct Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Germany

  • Study on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Alcoholic liver disease
    Denmark France Germany Greece Italy Poland +2
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!